Verekitug Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: UPB-101

Pipeline

Phase 2: 1

Top Sponsors

Upstream Bio Inc.1

Indications

Chronic Obstructive Pulmonary Disease1
COPD1

Bakersfield, California1 trial

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Kern Research Inc.

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.